A synthesis of 3'-deoxybutirosin B.
スポンサーリンク
概要
- 論文の詳細を見る
3′-Deoxybutirosin B (<B>13</B>) was prepared from 3′-deoxyparomamine (<B>1</B>), D-ribose and (<I>S</I>)-4-amino-2-hydroxybutyric acid (AHBA). The synthesis involves replacement of the 6′-hydroxyl group of 3′-deoxyparomamine with azido group, 1,6-carbamate ring formation, condensation with tri-<I>O</I>-(<I>p</I>-nitrobenzovl)-α,β-D-ribofuranosyl bromide, selective cleavage of the carbamate ring, and acylation of the free amino group at C-1 with AHBA.
- 公益社団法人 日本化学会の論文
著者
-
Tsuchiya Tsutomu
Institute of Bioorganic Chemistry
-
Umezawa Sumio
Institute of Bioorganic Chemistry
-
Ikeda Daishiro
Institute of Bioorganic Chemistry
-
Ejima Akio
Institute of Bioorganic Chemistry
-
Watanabe Isamu
Institute of Bioorganic Chemistry
関連論文
- Structure of Ericamycin Having a 2-Azhexaphene Ring System
- Selective Deoxygenation and O-Methylation of Benanomicin A:Synthesis of 9-Deoxy-, 9-O-Methyl- and 14-O-Methylbenanomicin A
- A Synthetic Approach to Benanomicin A 2. Synthesis of the Substituted 5,6-Dihydrobenzo[a]naphthacenequinone
- A Synthetic Approach to Benanomicin A 1. Synthesis of 5,6-Dihydrobenzo[a]naphthacenequinone
- Synthesis an Optically Active α-Tetralone : A Key Intermediate to Natural Benanomicinone
- Inhibitory Activity of Dome Formation in LLC-PK_1 Cells Is a Selective Index of Aminoglycoside Nephrotoxicity
- Tyropeptins A and B, New Proteasome Inhibitors Produced by Kitasatospora sp. MK993-dF2 : II. Structure Determination and Synthesis
- Heliquinomycin, a New Inhibitor of DNA Helicase, Produced by Streptomyces sp. MJ929-SF2 II. Structure Determination of Heliquinomycin
- Decatromicins A and B, New Antibiotics Produced by Actinomadura sp. MK73-NF4 II. Structure Determination
- Citric acid inhibits a bacterial ceramidase and alleviates atopic dermatitis in an animal model
- Reactions of benzyl 2-benzyloxycarbonylamino-2-deoxy-3-O-mesyl-.ALPHA.-D-gluco- and -.ALPHA.-D-allopyranoside derivative with iodide.
- Syntheses of 23-C-substituted derivatives of mycaminosyl tylonolide and 4'-deoxymycaminosyl tylonolide.
- Transformation of dihydrostreptomycin into 3"-deoxydihydrostreptomycin.
- A synthesis of 3'-deoxybutirosin B.
- Structural studies on the cyclic carbamate derivatives of kanamycin A.
- Synthesis of 5-O- and 6-O-methyldihydrostreptomycin.
- Studies on O.RAR.N acyl migration in O-acyl-2-deoxystreptamines.
- Syntheses of 1-epikanamycin A and its 1-N-((S)-4-amino-2-hydroxybutyryl) derivative.
- Syntheses of lividomycin B analogues, 5-O-(3-O-(6-amino-6-deoxy-.BETA.-L-idopyranosyl)-.BETA.-D-ribofuranosyl)-3'-deoxyparomamine and 5-O-(2-O-(6-amino-6-deoxy-.BETA.-L-idopyranosyl)-.BETA.-D-ribofuranosyl)-3'-deoxyparomamine.
- Syntheses of 2',3'-dideoxykanamycin A, 2',3'-dideoxyamikacin and related substances.
- The total synthesis of neomycin C.
- Syntheses of recyclized macrolide antibiotics and related derivatives from mycaminosyltylonolide.
- Reactions of 2-guanidino-1-cyclohexanol with ketals and acetals.
- Synthesis of 5"-deoxy-5"-fluorolividomycin B.
- Synthesis of 2-amino-2,3-dideoxy-L-ribohexose.
- Synthesis of a masked derivative of 3'-deoxydihydrostreptobiosamine, a precursor for the synthesis of 3"-deoxydihydrostreptomycin.
- A synthesis of neamine.
- Synthesis of a lividomycin B analogue, 5-O-[3-O-(2-amino-2-deoxy-.ALPHA.-D-glucopyranosyl)-.BETA.-D-ribofuranosyl]-3'-deoxyparomamine.
- Suppression of type II collagen-induced arthritis by ICM0301B, a new angiogenesis inhibitor